Brello vs Fridays: Pricing, Medications, and Program Structure

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies, weight management, and the genetics behind every metabolic decision. Browse all Peptides & GLP-1 education.

This is independent editorial commentary. PlexusDx has no commercial relationship with Brello or Fridays, uses no affiliate links, and received no compensation for this comparison.

Full head-to-head: PlexusDx vs Fridays →

Someone comparing Brello and Fridays is really asking a pricing-and-structure question: two GLP-1 telehealth brands, similar molecules, different terms. This piece lines them up as of April 2026, leans on published rates only where a brand states them, and points you back to each source for anything that can move overnight.

Brello at a glance

Brello (Brello Health) runs a telehealth-plus-compounding model. A licensed provider evaluates the patient, and eligible prescriptions are filled either as branded FDA-approved GLP-1 products or as compounded semaglutide or tirzepatide through a 503A pharmacy. Check Brello's own site for its current menu and terms at the time you read this.

Fridays at a glance

Fridays (Fridays Health) operates the same telehealth-plus-compounding structure, with published rates on its official website. As of Fridays' own pricing page (joinfridays.com/pricing, verified 2026-07-20), it advertised compounded semaglutide at $249/mo and compounded tirzepatide at $359/mo as ongoing month-to-month rates, with $0 membership, free shipping, and coaching and dietitian support included. Prepaid multi-month bundles lower the per-month equivalent; a paid-annually plan worked out to roughly $150/mo for semaglutide and $240/mo for tirzepatide.

Where the money goes

Fridays' rates moved materially within a single day, which is exactly why secondhand figures age badly — verify both brands at their own pricing pages before deciding. For reference, PlexusDx leads with month-to-month pricing of $189/mo for Semaglutide Injection and $289/mo for Tirzepatide Injection, roughly $60 to $70 below Fridays' advertised month-to-month for each compound; Fridays also sells prepaid 3- and 6-month bundles. The right answer depends on whether you prefer flexibility or a prepaid commitment.

The pharmacology both share

Neither brand owns the science. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide modulate appetite, satiety, and gastric emptying identically regardless of storefront. The trial record — STEP for semaglutide (NEJM, 2021), SURMOUNT for tirzepatide (NEJM, 2022), and SURMOUNT-OSA (NEJM, 2024) — belongs to the compound, not the platform.

Flexibility versus commitment

The core trade-off between these programs is contractual, not chemical. Month-to-month billing keeps you free to pause or switch, while prepaid multi-month bundles trade that freedom for a lower effective rate. Fridays' own annual figures show how steep that discount can be. Decide which you value more before letting a per-month number settle the question. If you are early in a trial-and-error phase, flexibility usually wins; once you are settled on a compound and dose, a prepaid plan can reward that certainty with real savings.

The genetic context neither includes

Both brands prescribe into a biology they never chart. TCF7L2, tied to glucose homeostasis and GLP-1 secretion, sits alongside GLP1R, FTO, and MC4R as pathway-level markers of your baseline metabolic terrain. They do not predict any compound's effect, but they describe what a clinician is prescribing into. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights. PlexusDx also offers the compounds themselves through its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral — and the genetic test does not predict response to any specific medication.

Independence note: PlexusDx is not affiliated with Brello or Fridays and reviewed both as market education.

More reading: GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1, and GLP 1 What Is.

Editorial disclaimer: This comparison is educational. PlexusDx has no tie to Brello or Fridays but sells semaglutide and tirzepatide through its own protocols, so treat this as a disclosed, interested viewpoint. The Precision Peptide Genetic Test maps gene-pathway influences and does not predict medication response. Consult a qualified provider before starting any protocol.

Compare directly: view the PlexusDx Weight Management Protocols, or start with the Precision Peptide Genetic Test.

Frequently Asked Questions

Is Brello or Fridays cheaper?

It depends on commitment. As of its verified 2026-07-20 pricing page, Fridays listed compounded semaglutide at $249/mo and tirzepatide at $359/mo month-to-month, with prepaid annual plans lowering those to roughly $150 and $240. Brello posts its own rates, so compare both at the source before deciding.

Do month-to-month or prepaid plans cost less?

Generally prepaid multi-month bundles reduce the per-month figure while month-to-month keeps flexibility. Fridays' annual plan illustrates the trade-off clearly. PlexusDx leads with month-to-month pricing of $189 for Semaglutide Injection and $289 for Tirzepatide Injection; weigh flexibility against a longer commitment.

Does the genetic test change which brand I should pick?

No. The Precision Peptide Genetic Test analyzes pathway-level variants in TCF7L2, and related genes describing baseline metabolism. That context applies whichever brand prescribes, and it never predicts how you will respond to a specific compound or which program suits you best.

Continue learning at the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.